May 3, 2026 10 min read FDA & Policy FDA sets July 2026 PCAC review for key compounding peptides (BPC-157, MOTs-C, Semax) FDAs July 2324, 2026 PCAC agenda puts seven peptides (BPC-157, KPV, TB-500, MOTs-C, DSIP, Semax, E
The College of Physicians and Surgeons of British Columbia said (new window) it doesn't have specific guidance on prescribing oral BPC-157, but expects licensees to exercise professional judgment to ensure they are providing safe and appropriate patient care
A 2003 study found that 2-3 years of treatment with Thymalin was shown to reduce all-cause mortality for elderly volunteers by a factor of two
Cardiac research has examined TB-500's effects on heart tissue repair and remodeling following injury
Bacteriostatic water has been established as a safe and efficient reagent for the reconstitution of peptides, however there are some possible caveats to consider